Source: Health Canada shortage reports · Updated Oct 16, 2026
A shortage of Milrinone is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 / 2
Reports on file
15
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Apr 22, 2024 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Mar 31, 2023
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Mar 31, 2023
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Nov 1, 2022
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Nov 1, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Aug 24, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Jul 31, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Jul 31, 2022 · Delay in shipping of the drug.
Discontinued
MILRINONE LACTATE INJECTION
1MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02244854
Resolved
MILRINONE LACTATE INJECTION
1MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02244854 · ended Jun 17, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Apr 30, 2022 · Demand increase for the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Milrinone to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Milrinone is classified under “CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES” (ATC C01CE).
Recent changes
Oct 16, 2026
New report filed
Common questions
When will Milrinone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Milrinone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.